PropertyValue
?:abstract
  • The in vivo phenotypic profile of T cells reactive to severe acute respiratory syndrome (SARS)-CoV-2 antigens remains poorly understood. Conventional methods to detect antigen-reactive T cells require in vitro antigenic re-stimulation or highly individualized peptide-human leukocyte antigen (pHLA) multimers. Here, we used single-cell RNA sequencing to identify and profile SARS-CoV-2-reactive T cells from Coronavirus Disease 2019 (COVID-19) patients. To do so, we induced transcriptional shifts by antigenic stimulation in vitro and took advantage of natural T cell receptor (TCR) sequences of clonally expanded T cells as barcodes for \'reverse phenotyping\'. This allowed identification of SARS-CoV-2-reactive TCRs and revealed phenotypic effects introduced by antigen-specific stimulation. We characterized transcriptional signatures of currently and previously activated SARS-CoV-2-reactive T cells, and showed correspondence with phenotypes of T cells from the respiratory tract of patients with severe disease in the presence or absence of virus in independent cohorts. Reverse phenotyping is a powerful tool to provide an integrated insight into cellular states of SARS-CoV-2-reactive T cells across tissues and activation states.
is ?:annotates of
?:creator
?:doi
?:doi
  • 10.1101/2020.12.07.20245274
?:license
  • medrxiv
?:pdf_json_files
  • document_parses/pdf_json/5fe6613aa8b24177c159d0451084e53abe7ec09c.json
?:publication_isRelatedTo_Disease
?:sha_id
?:source
  • MedRxiv; WHO
?:title
  • Single-cell RNA sequencing reveals in vivo signatures of SARS-CoV-2-reactive T cells through \'reverse phenotyping\'
?:type
?:year
  • 2020-12-08

Metadata

Anon_0  
expand all